Related Experiment Video
Updated: Aug 19, 2026
Methyl-binding DNA capture Sequencing for Patient Tissues
Published on: October 31, 2016
A methylation sensitive dot blot assay (MS-DBA) for the quantitative analysis of DNA methylation in clinical samples
1Institut de Pathologie, Centre Hospitalier Universitaire Vaudois, Bugnon 25, 1011 Lausanne, Switzerland.
Background:
There is increasing interest in DNA methylation and in its implication in transcriptional gene silencing, a phenomenon commonly seen in human cancer.
Aims:
To develop a new method that would allow quantitative DNA methylation analysis in a large range of clinical samples, independently of the processing protocol.
Methods:
A methylation sensitive dot blot assay (MS-DBA) was developed, which is quantitative and combines bisulfite modification, PCR amplification using primers without CpG sites, and dot blot analysis with two probes specific for methylated and unmethylated DNA.
Results:
The established method was used to study methylation of the hTERT, APC, and p16 promoter regions in microdissected, formalin fixed and paraffin wax embedded tissues.
Conclusions:
MS-DBA is a sensitive, specific, and quantitative approach to analyse DNA methylation in a variety of frozen or fixed tissues. Moreover, MS-DBA is rapid, easy to perform, and permits the screening of a large panel of samples in one experiment. Thus, MS-DBA can facilitate the routine analysis of DNA methylation in all types of clinical samples.
